PSY105 - COST-UTILITY OF NINTEDANIB VERSUS PIRFENIDONE FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS- A BELGIAN PERSPECTIVE
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2680
https://www.valueinhealthjournal.com/article/S1098-3015(18)35982-5/fulltext
Title :
PSY105 - COST-UTILITY OF NINTEDANIB VERSUS PIRFENIDONE FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS- A BELGIAN PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35982-5&doi=10.1016/j.jval.2018.09.2680
First page :
Section Title :
Open access? :
No
Section Order :
2033